Physician profile
Eric Kirschner
NPI 1902953490
$1,387.17
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,387.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $358.15 | 2019 | |
| Glaxosmithkline, LLC. | $183.67 | 2019 | |
| Pfizer INC. | $116.43 | 2019 | |
| Amgen INC. | $83.54 | 2019 | |
| Amarin Pharma, INC. | $70.45 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $70.30 | 2019 | |
| Janssen Pharmaceuticals, INC | $45.54 | 2019 | |
| Gilead Sciences, INC. | $38.79 | 2019 | |
| Sanofi Pasteur INC. | $37.48 | 2019 | |
| Boston Scientific Corporation | $35.12 | 2019 | |
| Lilly USA, LLC | $35.07 | 2019 | |
| Advanced Respiratory, INC | $30.62 | 2019 | |
| Grifols USA, LLC | $24.90 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.81 | 2019 | |
| Astellas Pharma US INC | $24.63 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $23.24 | 2019 | |
| Electromed, INC. | $21.35 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $21.25 | 2019 | |
| Insmed, INC. | $20.64 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.84 | 2019 | |
| Janssen Biotech, INC. | $19.65 | 2019 | |
| Philips North America LLC | $18.35 | 2019 | |
| Shire North American Group INC | $16.88 | 2019 | |
| Merck Sharp & Dohme LLC | $12.20 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.75 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.32 | 2019 | |
| Allergan, INC. | $11.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kirschner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.